Table 2.
PDUS performedN=402 | PDUS enthesitisN (%) | Sensitivity(IC 95%) | Specificity(IC 95%) | PPV(IC 95%) | NPV(IC 95%) |
PDUS enthesitis at any site | 58(14.4%) | 13.9%(9.9 to 17.9) | 83.5%(76.5 to 90.4) | 69%(57 to 80.9) | 26.8%(22.1 to 31.5) |
Achille’s PDUS enthesitis | 15(3.7%) | 4%(1.8 to 6.4) | 97%(94.2 to 100) | 80%(59.7 to 100) | 28%(23.2 to 32.2) |
Patellar ligaments PDUS enthesitis | 36(9%) | 8%(5.1 to 11.5) | 89%(83.1 to 94.8) | 67%(51.2 to 82.1) | 27%(22.2 to 31.4) |
Lateral epicondyle PDUS enthesitis | 20(5%) | 5%(2.4 to 7.3) | 94%(90.2 to 98.7) | 70%(49.9 to 90.1) | 27%(22.8 to 31.8) |
The sensitivity and specificity of PDUS-defined enthesitis were calculated on the 402 patients who underwent PDUS, using classification as axial spondyloarthritis according to the ASAS criteria as the reference standard (n=288 patients met these criteria).
ASAS, Assessment of SpondyloArthritis international Society; DESIR, DEvenir des Spondylarthropathies Indifférenciées Récentes; NPV, negative predictive value; PDUS, power Doppler ultrasonography; PPV, positive predictive value.